Key Takeaways
- • Blackstone and TPG have successfully completed a take-private transaction of Hologic, a women's health company, establishing significant control of a major player in the medical device and diagnostic sectors.
- • The deal structure includes minority equity investments from the Abu Dhabi Investment Authority (via subsidiary) and GIC (via affiliate), indicating substantial international institutional capital participation alongside the two leading alternative asset managers.
- • The transaction represents a consolidation of ownership under experienced private equity sponsors, transitioning Hologic from public market scrutiny to a privately-controlled structure focused on operational and strategic optimization.
Summary
Blackstone and TPG have finalized their acquisition of Hologic, taking the women's health company private in a significant transaction that underscores sustained private equity interest in healthcare assets. The completed buyout positions both sponsors as controlling partners in a company with established market presence in medical devices and diagnostics, a sector that continues to attract substantial capital from large institutional investors.
The transaction's financial structure extends beyond the two primary sponsors. The Abu Dhabi Investment Authority and GIC—both global sovereign wealth and institutional investors—have assumed minority equity positions in the deal through subsidiary and affiliate entities, respectively. This multi-sponsor approach reflects the scale and strategic value of the acquisition, distributing capital among world-class institutional investors while maintaining operational control under Blackstone and TPG's joint management framework.
The completion of this take-private transaction removes Hologic from public equity markets, enabling the new ownership group to pursue longer-term value creation strategies without quarterly earnings pressures. For investors in Blackstone and TPG funds, the deal demonstrates the sponsors' continued ability to source and execute large-scale healthcare transactions, a sector category that has remained resilient and strategically relevant through multiple market cycles. The participation of sovereign wealth funds and Asia-Pacific institutional capital further validates the transaction's strategic and financial fundamentals at completion.
The transaction's financial structure extends beyond the two primary sponsors. The Abu Dhabi Investment Authority and GIC—both global sovereign wealth and institutional investors—have assumed minority equity positions in the deal through subsidiary and affiliate entities, respectively. This multi-sponsor approach reflects the scale and strategic value of the acquisition, distributing capital among world-class institutional investors while maintaining operational control under Blackstone and TPG's joint management framework.
The completion of this take-private transaction removes Hologic from public equity markets, enabling the new ownership group to pursue longer-term value creation strategies without quarterly earnings pressures. For investors in Blackstone and TPG funds, the deal demonstrates the sponsors' continued ability to source and execute large-scale healthcare transactions, a sector category that has remained resilient and strategically relevant through multiple market cycles. The participation of sovereign wealth funds and Asia-Pacific institutional capital further validates the transaction's strategic and financial fundamentals at completion.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.